Embedding a COVID-19 group sequential clinical trial within an ongoing trial: lessons from an unusual experience
- PMID: 34191980
- PMCID: PMC8008347
- DOI: 10.1080/19466315.2020.1800509
Embedding a COVID-19 group sequential clinical trial within an ongoing trial: lessons from an unusual experience
Abstract
The Cape-Covid trial is an embedded clinical trial within the ongoing Cape-Cod trial. The Covid-19 pandemic appeared while we were conducting a randomized trial assessing the effectiveness of corticosteroids in severe community-acquired pneumonia. We took advantage of this ongoing trial to embed a sub-trial assessing hydrocortisone in SARS-CoV-2 infected patients. In this manuscript, we wish to share our experience when we needed to make fast and robust methodological decisions during the Covid-19 pandemic in a two weeks period of time.
Keywords: SARS-CoV-2 virus; group-sequential designs.
© 2020 American Statistical Association.
Figures
References
-
- Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemic [Internet]. [cited 2020 May 8]. Available from: https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-10/gui...
-
- London AJ, Kimmelman J. Against pandemic research exceptionalism. Science. 2020 May 1;368(6490):476–7. - PubMed
-
- Whitehead, J., & Stratton, I. (1983). Group Sequential Clinical Trials with Triangular Continuation Regions. Biometrics, 39(1), 227-236. - PubMed
-
- Pocock, S.J. (1977). Group sequential methods in the design and analysis of clinical trials. Biometrika, 64, 191-199.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous